• Home
  • Authors
  • Write for us
  • Advertise
  • Contact
  • Privacy Policy
  • Terms and Conditions
Sunday, January 17, 2021
No Result
View All Result
ABC Money
PR Fire Press Release Distribution
  • News
  • Business
  • Economics
  • Finance
    • Investment
    • Tax
    • Mortgage
  • Property
    • Utilities
  • World
  • Technology
  • Fashion
  • Health
  • Holidays
  • News
  • Business
  • Economics
  • Finance
    • Investment
    • Tax
    • Mortgage
  • Property
    • Utilities
  • World
  • Technology
  • Fashion
  • Health
  • Holidays
ABC Money
No Result
View All Result
Home Business

Pfizer ends trials of PF-3512676 as lung cancer treatment UPDATE

by Joseph Beale
14/12/2017

RelatedPosts

How to Get Started as A Freelancer

How Much Money Can You Earn as a Nail Technician?

Problems and Solutions of Working Through Quarantine

The Different Supply Chain Models Explained

Load More

LONDON (Thomson Financial) – Pfizer Inc said it has ended trials of PF-3512676 in combination with cytotoxic chemotherapy as a treatment for lung cancer.The company said this includes two Phase 3 and two Phase 2 clinical trials.Pfizer said an interim analysis of the Phase 3 trials by an independent data safety monitoring committee (DSMC) showed there was no evidence that PF-3512676 produced additional clinical efficacy over that achieved with the standard cytotoxic chemotherapy regimen alone.’The DSMC concluded that the risk-benefit profile did not justify continuation of the trials,’ the company said.Pfizer said it licensed PF-3512676 from Coley Pharmaceutical Group Inc in 2005.tf.TFN-Europe_newsdesk@thomson.comwjCOPYRIGHTCopyright AFX News Limited 2007. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.

Previous Post

News Corp. reaches deal to buy Dow Jones

Next Post

N.M.: Company fined in fireworks case

Related Posts

How to Get Started as A Freelancer
Business

How to Get Started as A Freelancer

15/01/2021
How Much Money Can You Earn as a Nail Technician?
Business

How Much Money Can You Earn as a Nail Technician?

15/01/2021
Problems and Solutions of Working Through Quarantine
Business

Problems and Solutions of Working Through Quarantine

15/01/2021
Next Post

N.M.: Company fined in fireworks case

Synthes has setback in FDA panel backing of Medtronic spinal disk - report

New group lobbies against Internet fraud

Latest News

How To Dedicate Yourself To The World Of Animation In Spain

How To Dedicate Yourself To The World Of Animation In Spain

17/01/2021
Giant Of The Call Centers That Bets By The Networks

Giant Of The Call Centers That Bets By The Networks

04/01/2021
Big Funds Look For Bargains In Spain

Big Funds Look For Bargains In Spain

04/01/2021
Bridge International Academies (Kenya/Nigeria/Uganda) Offers Education for All

Bridge International Academies (Kenya/Nigeria/Uganda) Offers Education for All

15/01/2021
The prognosis for Bitcoin in 2021

The prognosis for Bitcoin in 2021

15/01/2021
Rideshare Insurance for Drivers: What it Covers in an Accident

Rideshare Insurance for Drivers: What it Covers in an Accident

15/01/2021

Social

Contact

For editorial enquiries:

editorials@abcmoney.co.uk

For advertising enquiries:

advertise@abcmoney.co.uk

Top Topics

  • News
  • Business
  • Finance
  • Property
  • Technology
  • Investment

Guides

  • Best UK Bridging Loans
  • Best UK Secured Loans
  • Best UK Commercial Mortgages
  • Best UK Business Loans
  • Best UK Payday Loans
  • Best Sites for International Money Transfers
  • Best Press Release Distribution Service

Social

  • Home
  • Authors
  • Write for us
  • Advertise
  • Contact
  • Privacy Policy
  • Terms and Conditions

© 2020 ABC Money

No Result
View All Result
  • Write for us
  • Contact
  • About Us
    • Authors
  • News Desk
    • Business
    • Finance
    • Property
    • Technology
    • Investment

© 2020 ABC Money

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.